Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and atorvastatin before prostatectomy for prostate cancer
ACTRN12615000571572Phase 2Suspended
- Sponsor
- University of Queensland Centre for Clinical Research
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metformin and atorvastatin in prostate cancer (PCa) (4 arms), sponsored by University of Queensland Centre for Clinical Research. Primary endpoints: Change in histology between biopsy and prostatectomy, Metabolic changes in ejaculate and 1 more. Started Mar 2015; status: suspended.
02
Drugs
metforminatorvastatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on ACTRN12615000571572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000571572.